Actively Recruiting
Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Led by Ruijin Hospital · Updated on 2022-10-10
710
Participants Needed
11
Research Sites
416 weeks
Total Duration
On this page
Sponsors
R
Ruijin Hospital
Lead Sponsor
D
Dongfang Hospital Affiliated to Tongji University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.
CONDITIONS
Official Title
Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 85 years
- Tumor located in the colon or high rectum (above the peritoneal reflection)
- Pathological or highly suspected colorectal carcinoma
- Clinical diagnosis of cT1-4aN0-2 M0 lesions based on AJCC 8th Edition
- Tumor size of 5 cm or less
- ECOG performance status score of 0 to 1
- ASA physical status score of I to III
- Provided informed consent
You will not qualify if you...
- Body mass index (BMI) greater than 35 kg/m2
- Tumor located below the peritoneal reflection
- Familial adenomatous polyposis (FAP)
- Inflammatory bowel disease (IBD)
- Multiple malignant colorectal tumors
- Pregnant or breastfeeding women
- Severe mental illness
- Previous gastrointestinal surgery except appendectomy
- Emergency surgery due to bleeding, perforation, or obstruction from colorectal cancer
- Need for simultaneous surgery for other diseases
- Simultaneous or metachronous multiple cancers with disease-free survival less than or equal to 5 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
The 940th Hospital of Joint Logistic Support Force of Chinese of PLA
Lanzhou, Gansu, China, 730050
Actively Recruiting
2
Shengjing Hospital
Shenyang, Liaoning, China, 110004
Actively Recruiting
3
Liaoning Tumor Hospital & Institute
Shenyang, Liaoning, China, 110801
Actively Recruiting
4
Shandong Provincial Hospital
Jinan, Shandong, China, 250021
Actively Recruiting
5
The General Hospital of Western Theater Command
Chengdu, Sichuan, China, 610083
Actively Recruiting
6
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China, 310014
Actively Recruiting
7
Shanghai Cancer Center
Shanghai, China, 200032
Actively Recruiting
8
Dongfang Hospital Affiliated to Tongji University
Shanghai, China, 200120
Actively Recruiting
9
RenJi Hospital
Shanghai, China, 200127
Actively Recruiting
10
Changhai Hospital
Shanghai, China, 200438
Actively Recruiting
11
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China, 201801
Actively Recruiting
Research Team
R
Ren Zhao, MD, PHD
CONTACT
K
Kun Liu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here